We showed that the dietary supplementation with β-carotene delays atherosclerosis progression by reducing cholesterol hepatic secretion in low-density lipoprotein receptor (LDLR)-deficient (Ldlr-/-) mice (Zhou et al., 2020). This evidence concerns the gene VLDLR and atherosclerosis.